The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders

Post‐transplant lymphoproliferative disorders (PTLD) and Burkitt's lymphoma (BL) are B‐cell malignancies strongly associated with Epstein–Barr virus (EBV) infection. In these lymphoproliferative disorders, EBV infection induces an increase in the expression of the anti‐apoptotic protein BCL‐2....

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Aude, Pujals, Anaïs, Favre, Loetitia, Debernardi, Justine, Wiels, Joëlle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530790/
https://www.ncbi.nlm.nih.gov/pubmed/32623836
http://dx.doi.org/10.1002/1878-0261.12759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530790/
https://www.ncbi.nlm.nih.gov/pubmed/32623836
http://dx.doi.org/10.1002/1878-0261.12759

Ejemplares similares